programs in gout andcancer Gout First and next-generation URAT1 transporter inhibitors for the treatment of hyperuricemia and gout Cancer BAY 86-9766 (formerly known as RDEA119...

URAT1 transporter inhibitors for the treatment of hyperuricemia and gout Cancer BAY 86-9766 (formerly known as RDEA119), a mitogen-activated ERK kinase (MEK) inhibitor...

with limited treatment options. In the last 40 years, only two new medications have received FDA approval for the treatment of hyperuricemia associated with gout. Gout is a painful... flares) and kidney damage (nephropathy). In addition, evidence suggests that the chronic elevation of uric acid associated with gout, known as hyperuricemia, may also have systemic... Resources RDEA594 RDEA594, our most advanced product candidate for the chronic management of hyperuricemia and gout, is an oral, once-daily inhibitor of URAT1, a transporter...

subsequently developed product candidates for thechronic managementof hyperuricemia in gout patients through our own proprietary research and development efforts. On June 19, 2012...

in the Treatment of Hyperuricemia in Gout Patients 03/12/10 Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook;AnnouncesFourth Quarterand Full-Year 2009 Financial...